Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 5, 2000, Pages 344-354

  Abe, Yasuyo ^a   Kawakami, Atsushi ^a   Nakashima, Tomoki ^a   Ejima, Eri ^a   Fujiyama, Kaoru ^a   Kiriyama, Takeshi ^a   Ide, Akane ^a   Sera, Nobuko ^a   Usa, Toshiro ^a   Tominaga, Tan ^a   Ashizawa, Kiyoto ^a   Yokoyama, Naokata ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033747980     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.109757     Document Type: Article

References (42)

1. Diphosphonate therapy of Paget’s disease of bone
2. Prevention of postmenopausal bone loss by tiludronate
3. Pamidronate reduces PTH-mediated bone loss in a gene transfer model of hyper-parathyroidism in rats
4. Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function
5. Increased bone mass with pamidronate treatment in rheumatoid arthritis
6. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates
7. Bisphosphonates: Mechanisms of action
8. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro
9. Osteoclast recruitment in mice is stimulated by 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate
10. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow
11. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
12. Bisphosphonates: From the laboratory to the clinic and back again
13. The cells of bone
14. Inhibition of osteoblastgenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone
15. Ceramide induced AP-1 activation is a mediator of apoptotic response to TNF-α in periarticular osteoblasts in patients with rheumatoid arthritis
16. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis
17. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
18. Cytokine expression in synovial membranes of patients with rheumatoid arthritis
19. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis
20. Interleukin-6 in synovial fluid and Serum of patients with rheumatoid arthritis and other inflammatory arthritis
21. Generalized bone loss in patients with early rheumatoid arthritis
22. Bone mineral density of the hand in rheumatoid arthritis
23. Inhibitory effect of glucocorticoid for osteoblast apoptosis induced by activated peripheral blood mononuclear cells
24. Inhibition of antigen-presenting cell function by alendronate in vitro
25. Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage
26. Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages
27. Osteoblastic cells are involved in osteoclast formation
28. The quantitative histochemistry of brain
29. Effect of Bcl-2 on Fas antigen-mediated cell death
30. Bcl-XL and Bcl-2 repress a common pathway of cell death
31. Clinical features of rheumatoid arthritis
32. Bone mass in patients with rheumatoid arthritis
33. Bone mineral density in ambulant non-steroid treated female patients with rheumatoid arthritis
34. Risedronate
35. Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis
36. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
37. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
38. Role of cytokines in bone resorption
39. Tumor necrosis factor-a can stimulate bone resorption in cultured mouse calvariae by a prostaglandin-independent mechanism
40. Induction of apoptosis in murine clonal osteoblasts expressed by human T-cell leukemia virus type I tax by NF-kB and TNF-a
41. Ceramide-induced nuclear translocation of NF-kB is a potential mediator of the apoptotic response to TNF-a in murine clonal osteoblasts
42. Tumor necrosis factor-a and interleukin-1b increase the Fas-mediated apoptosis of human osteoblasts